Literature DB >> 9441697

Cyclooxygenase-1 and cyclooxygenase-2 in the human optic nerve head.

A H Neufeld1, M R Hernandez, M Gonzalez, A Geller.   

Abstract

To investigate the hypothesis that eicosanoids act as cellular mediators in the optic nerve head of normals and of patients with glaucoma, we have determined the presence of the two cyclooxygenase (COX) isoforms in human tissue. Histological sections of optic nerve heads were studied by immunohistochemistry. Age matched normal donors were compared with eyes from glaucoma patients with moderate to severe nerve damage. Polyclonal antibodies to human COX-1 and COX-2 were localized with immunoperoxidase staining. Specific antibodies for vascular endothelia and microglia were also colocalized. In normal and glaucomatous eyes. COX-1 was localized exclusively to the prelaminar and lamina cribrosa regions of the optic nerve head. No staining for COX-1 was observed in the nerve fiber layer or the myelinated optic nerve. COX-1 was associated with the astrocytes of the glial columns and the cribriform plates, but not with the endothelia lining the capillaries. In glaucoma, more astrocytes appeared to be stained with antibody to COX-1 than in normals and staining was intensely perinuclear. There was no staining for COX-2 in normal tissue. A few COX-2 positive cells were found in the prelaminar, lamina cribrosa and postlaminar regions of the glaucomatous optic nerves. Positive staining for COX-2 was not associated with microglia. COX-1 is constitutively present in astrocytes that are localized exclusively to the prelaminar and lamina cribrosa regions of the human optic nerve head. Eicosanoids, synthesized by COX-1 in this tissue, may have a homeostatic and a neuroprotective role related to the axons of the retinal ganglion cells. The sparse presence of COX-2 in glaucomatous tissue probably reflects the lack of inflammation associated with glaucomatous optic neuropathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9441697     DOI: 10.1006/exer.1997.0394

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  7 in total

Review 1.  Ganglion cell death in glaucoma: what do we really know?

Authors:  N N Osborne; J P Wood; G Chidlow; J H Bae; J Melena; M S Nash
Journal:  Br J Ophthalmol       Date:  1999-08       Impact factor: 4.638

2.  Metal chelator combined with permeability enhancer ameliorates oxidative stress-associated neurodegeneration in rat eyes with elevated intraocular pressure.

Authors:  P Liu; M Zhang; M Shoeb; D Hogan; Luosheng Tang; M F Syed; C Z Wang; G A Campbell; N H Ansari
Journal:  Free Radic Biol Med       Date:  2014-02-06       Impact factor: 7.376

3.  Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients.

Authors:  Li-chen Gao; Di Wang; Fang-qun Liu; Zheng-yu Huang; Hong-guang Huang; Gui-hua Wang; Xi Chen; Qun-zhi Shi; Li Hong; Li-ping Wu; Jie Tang
Journal:  Eur J Clin Pharmacol       Date:  2014-10-23       Impact factor: 2.953

Review 4.  The immune response in glaucoma: a perspective on the roles of oxidative stress.

Authors:  Gülgün Tezel
Journal:  Exp Eye Res       Date:  2010-08-13       Impact factor: 3.467

5.  Fluorocoxib A enables targeted detection of cyclooxygenase-2 in laser-induced choroidal neovascularization.

Authors:  Md Jashim Uddin; Chauca E Moore; Brenda C Crews; Cristina K Daniel; Kebreab Ghebreselasie; J Oliver McIntyre; Lawrence J Marnett; Ashwath Jayagopal
Journal:  J Biomed Opt       Date:  2016-09-01       Impact factor: 3.170

6.  Down-regulation of the RNA editing enzyme ADAR2 contributes to RGC death in a mouse model of glaucoma.

Authors:  Ai Ling Wang; Reed C Carroll; Scott Nawy
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

Review 7.  Carotenoids in the Management of Glaucoma: A Systematic Review of the Evidence.

Authors:  Drake W Lem; Dennis L Gierhart; Pinakin Gunvant Davey
Journal:  Nutrients       Date:  2021-06-06       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.